학술논문

Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19.
Document Type
Journal Article
Source
BMC Neurology. 6/18/2020, Vol. 20 Issue 1, p1-5. 5p. 2 Black and White Photographs, 1 Chart, 1 Graph.
Subject
*COVID-19
*SARS-CoV-2
*NEUROLOGICAL disorders
*CEREBROSPINAL fluid examination
*SEIZURES (Medicine)
*CYTOKINES
*EPIDEMICS
*RESEARCH funding
*SPASMS
*VIRAL pneumonia
*ACUTE diseases
*VIRAL encephalitis
Language
ISSN
1471-2377
Abstract
Background: COVID-19 is caused by the severe acute respiratory syndrome virus SARS-CoV-2. It is widely recognized as a respiratory pathogen, but neurologic complications can be the presenting manifestation in a subset of infected patients.Case Presentation: We describe a 78-year old immunocompromised woman who presented with altered mental status after witnessed seizure-like activity at home. She was found to have SARS-CoV-2 infection and associated neuroinflammation. In this case, we undertake the first detailed analysis of cerebrospinal fluid (CSF) cytokines during COVID-19 infection and find a unique pattern of inflammation in CSF, but no evidence of viral neuroinvasion.Conclusion: Our findings suggest that neurologic symptoms such as encephalopathy and seizures may be the initial presentation of COVID-19. Central nervous system inflammation may associate with neurologic manifestations of disease. [ABSTRACT FROM AUTHOR]